F053 Vulvar Disease: What Do You Know? An Overview
DESCRIPTION
Nearly one in six women experience undiagnosed and untreated vulvovaginal discomfort during their lives. This forum will focus on management pearls for treating patients with vulvar dermatoses. Test your knowledge as speakers review cases highlighting challenging clinical scenarios.
LEARNING OBJECTIVES
Develop a practical, clinical approach to the evaluation of vulvar disorders
Assess, diagnose, and manage both common and more challenging vulvar dermatoses
Recognize the broad differential diagnosis of vulvar conditions using interactive clinicopathologic correlations
SCHEDULE
1:00 PM
Introduction and Welcome
Melissa Muszynski Mauskar, MD, FAAD
1:10 PM
Challenging cases with lichenoid and plasmacytic infiltrate
Christina Kraus, MD, FAAD
1:30 PM
Challenging cases in special populations
Olushola Akinshemoyin Vaughn, MD, FAAD
1:50 PM
Q/A
Melissa Muszynski Mauskar, MD, FAAD, Olushola Akinshemoyin Vaughn, MD, FAAD, Christina Kraus, MD, FAAD
2:00 PM
Interactive case presentations
Jill I. Allbritton, MD, FAAD
2:15 PM
Interactive case presentations
Alicia J Little, MD, PhD, FAAD
2:30 PM
Interactive case presentations
Audrey Kay Rutherford, MD, FAAD
2:45 PM
Q/A
Jill I. Allbritton, MD, FAAD, Alicia J Little, MD, PhD, FAAD, Audrey Kay Rutherford, MD, FAAD
DIRECTOR
Melissa Muszynski Mauskar, MD, FAAD
SPEAKERS
Olushola Akinshemoyin Vaughn, MD, FAAD
Jill I. Allbritton, MD, FAAD
Christina Kraus, MD, FAAD
Alicia J Little, MD, PhD, FAAD
Audrey Kay Rutherford, MD, FAAD
HANDOUTS
DISCLOSURES
Olushola Akinshemoyin Vaughn, MD, FAAD
No financial relationships exist with ineligible companies.
Jill I. Allbritton, MD, FAAD
US Dermatology Partners – Other(Stock);
Christina Kraus, MD, FAAD
Incyte – Investigator(Grants/Research Funding); Nuvig Therapeutics – Advisory Board(Honoraria);
Alicia J Little, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Melissa Muszynski Mauskar, MD, FAAD
Incyte Corporation – Investigator(Grants/Research Funding); Nuvig Therapeutics – Advisory Board(Honoraria);
Audrey Kay Rutherford, MD, FAAD
No financial relationships exist with ineligible companies.